Filing Details
- Accession Number:
- 0001125345-20-000009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-06 16:41:24
- Reporting Period:
- 2020-02-04
- Accepted Time:
- 2020-02-06 16:41:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1125345 | Macrogenics Inc | MGNX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1587774 | Blasius Eric Risser | 9704 Medical Center Drive Rockville MD 20850 | Sr Vp & Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-04 | 30 | $0.94 | 32,498 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-04 | 30 | $10.00 | 32,468 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-02-05 | 623 | $0.94 | 33,091 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-05 | 623 | $10.00 | 32,468 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee stock option (right to buy) | Disposition | 2020-02-04 | 30 | $0.94 | 30 | $0.94 |
| Common Stock | Employee stock option (right to buy) | Disposition | 2020-02-05 | 623 | $0.94 | 623 | $0.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,623 | 2012-09-14 | 2022-03-13 | No | 4 | M | Direct |
| 7,000 | 2012-09-14 | 2022-03-13 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019.
Billionaire Hedge Funds
